Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Stopping antibiotics early in older adults hospitalized with a viral lung infection

Official title: Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection

Run by Centre Hospitalier Universitaire, Amiens · NCT07030673 · Data updated 2026-11-12

This trial will test whether stopping antibiotics early is safe and helpful for people 65 and older who are hospitalized with a confirmed viral lower respiratory infection.

More Elderly (People Aged 65 or More) trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment256 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedFebruary 14, 2025
Main results expectedMarch 2027
Study endsJune 2027
Registry record updatedJanuary 16, 2026
Trial IDNCT07030673 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 65 or older who are hospitalized for a lower respiratory infection, have a microbiological diagnostic sample taken within 48 hours, and can provide informed consent (or have a representative who can).

Probably not a fit

Patients with septic shock, febrile aplasia, proven inhalation, purulent pleurisy or lung abscess, other bacterial infections requiring antibiotics, moribund patients, or those without timely microbiological sampling are unlikely to benefit from early antibiotic discontinuation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Older adults hospitalized with signs of lower respiratory infection will have microbiological sampling within 48 hours and multiplex PCR testing to identify viral pathogens. When a viral infection is identified and there is no evidence of bacterial co-infection, the protocol calls for early discontinuation of antibiotics; patients will then be followed for clinical outcomes, complications, and need to restart antibiotics. The intervention is being implemented at university hospitals in France and compared with usual antibiotic management pathways. The goal is to measure safety, clinical recovery, and antibiotic exposure in this higher-risk, comorbid population.

Why it matters

Potential benefit: If successful, the approach could safely reduce unnecessary antibiotic exposure, antibiotic-related side effects, and contribution to antimicrobial resistance in elderly inpatients.

How similar studies have gone: Previous antibiotic stewardship efforts using rapid viral testing have reduced antibiotic use in some adult populations, but robust evidence specifically in frail elderly inpatients is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients ≥ 65 years affiliated to a social security scheme
* Hospitalized for a lower respiratory infection defined as:

  * the presence of 2 of the following 4 signs:
  * hyperthermia \>38°C,
  * hyperleukocytosis ≥12000 or ≤4000,
  * purulent aspirations/sputum,
  * rales on pulmonary auscultation indicating parenchymal damage
  * associated with a pulmonary image (standard X-ray, CT scan or ultrasound)
* Microbiological diagnostic sample taken within 48 hours
* Informed consent of the patient or their representative

Exclusion Criteria:

* Hospitalization planned for \< 48 hours or transfer planned to another center within 7 days

  * Patient in septic shock,
  * Febrile aplasia
  * Absence of diagnostic microbiological sampling (\> 48 hours after admission)
  * Moribund patient,
  * Death expected within the week
  * Inhalation proven by endoscopy or eyewitness
  * Purulent pleurisy, lung abscess, or other concomitant bacterial infection requiring antibiotic therapy.

Where it's running

  • CHRU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.